The annual general meeting in ChromoGenics AB (publ) was held on 15 May 2019 at Advokatfirman Lindahl’s offices on Vaksalagatan 10 in Uppsala whereby the shareholders resolved on the following main matters.
Annual report and profit and loss statement
The annual general meeting adopted the presented profit and loss statement and the balance sheet and resolved, in accordance with the board of directors’ proposal, to carry the accumulated loss forward in new account. No dividends will be paid for the financial year 2018.
Discharge from liability
The board of directors and the managing